Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis (Q36072562)

12 August 2017

1 reference

title

Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis (English)

1 reference

Human T-lymphotropic virus 1

12 August 2017

0 references

Strongyloides stercoralis

0 references

1 reference

Carvalho EM

1

1 reference

PubMed ID

15771684

12 August 2017

Da Fonseca Porto A

series ordinal

2

1 reference

12 August 2017

1 November 2004

1 reference

12 August 2017

1 reference

12 August 2017

26

1 reference

12 August 2017

11-12

1 reference

12 August 2017

487-497

1 reference

I. THE PROBLEM OF STRONGYLOIDIASIS AMONG THE MENTALLY RETARDED IN INSTITUTIONS.

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Fatal strongyloidiasis in immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Strongyloides hyperinfection in patients coinfected with HTLV-I and S. stercoralis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Regulating the immune response to transplants. a role for CD4+ regulatory cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Virus-induced interferon alpha/beta (IFN-alpha/beta) production by T cells and by Th1 and Th2 helper T cell clones: a study of the immunoregulatory actions of IFN-gamma versus IFN-alpha/beta on functions of different T cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

High incidence of HTLV antibody in carriers of Strongyloides stercoralis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Autonomous and interleukin-2-responsive growth of leukemic cells in adult T-cell leukemia (ATL): a review of the clinical significance and molecular basis of ATL cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Strongyloidiasis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Duodenal obstruction caused by Strongyloides stercoralis enteritis in an HTLV-1-infected host

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

[Clinical study on ivermectin against 125 strongyloidiasis patients].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Reduced efficacy of chemotherapy might accumulate concurrent HTLV-1 infection among strongyloidiasis patients in Okinawa, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0141-9838.2004.00726.X

10.1111/J.0141-9838.2004.00726.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15771684